Login

Orbis' CEO Jani Linna-Aro interviews Phil Stanway from Huber+Suhner AG about their partnership and business insights. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"Join Mr. John Lai, CEO & President of PetVivo Holdings, Inc., for a revealing interview on the company's pioneering advancements and strategic vision."|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:10:00
Carlyle's Future: Strategic Updates and Investor Confidence Boost | Harvey Schwartz, CEO, Carlyle Group.
00:10:00
Mamba Exploration's Mike Dunbar on High-Grade Hyden REE Project Acquisition and Potential | Mike Dunbar , CEO ,Mamba Exploration.
00:10:00
Is Higher Inflation on the Horizon? Insights from Max Monk and Ryan Martin of Johnson Investment Counsel
00:10:00
Simon Garing, CEO of Cromwell European REIT, Explains Focus on Logistics Real Estate for Growth | Simon Garing , CEO , Cromwell European Real Estate Investment Trust .
00:10:00
Purdue Foundry Invests in High-tech Startups|Bill Arnold,Assistant Vice President,Heritage Grocers Group
00:00:00
Dr. Richard Lipscombe, Managing Director, Proteomics International Laboratories Lt
00:10:00
Paul Goldschmid of King Street Capital Management Shares Insights on Strategic Investments, Economic Cycles, Real Estate, and Direct Lending
00:10:00
Orbis' CEO Jani Linna-Aro interviews Phil Stanway from Huber+Suhner AG about their partnership and business insights.
00:10:00
"Dive into an exclusive interview with Mr. John Lai, CEO & President of PetVivo Holdings, Inc., as he shares groundbreaking developments and visionary strategies driving the company's success."|Mr. Lai has been a director and senior executive officer of P
00:10:00
8Common (8CO) Chairman, Nic Lim and CEO, Nick Gonios | Kah Wui “Nic” Lim, MD, 8Common Ltd8CO:ASX
00:10:00
Greg Foran on Leading Air New Zealand Through Turbulence and His Vision for the Future | Greg Foran, CEO, Air New Zealand Ltd .

© 2026 Nehu